C-MER Medical Holdings (HKSE:03309) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03309 C-MER Medical Holdings Ltd HKSE:03309
83 GF Score
Price HK$0.86
GF Value HK$2.77
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is C-MER Medical Holdings Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

HKSE:03309
83GF Score
C-MER Medical Holdings Ltd HKSE:03309
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?

Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued. The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77. GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.

Key valuation signals for HKSE:03309:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-MER Medical Holdings Business Description

Address 1-3 Pedder Street, Room 1535, China Construction Building, Central, Hong Kong, HKG
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score

Get the complete analysis for HKSE:03309

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.86
Price
HK$2.77
GF Value